Publications

03-29 05:50
 
Achilles tendinopathy-do plantaris tendon removal and Achilles tendon scraping improve tendon structure? A prospective study using ultrasound tissue characterisation
03-29 05:50
 
Ultrasonographic tissue characterisation of human Achilles tendons: quantification of tendon structure through a novel non-invasive approach
03-29 05:50
 
The effect of nasal tramazoline with dexamethasone in obstructive sleep apnoea patients
03-29 05:50
 
The effects of fentanyl, oxycodone, and butorphanol on gastrointestinal function in patients undergoing laparoscopic hysterectomy: a prospective, double-blind, randomized controlled trial
03-29 05:50
 
Phase II Single-Arm Study to Assess Trastuzumab and Vinorelbine in Advanced Breast Cancer Patients With HER2-Negative Tumors and HER2-Positive Circulating Tumor Cells
03-29 05:50
 
Pharmacologically-induced mitotic synchrony in airway epithelial cells as a mechanism of action of anti-inflammatory drugs
03-29 05:50
 
VBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in mice
03-29 05:50
 
VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects
03-29 05:50
 
Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy
03-29 05:50
 
Biomarker-focused multi-drug combination therapy and repurposing trial in mdx mice
03-29 05:50
 
Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boys
03-29 05:50
 
Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit
03-29 05:50
 
Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone
03-29 05:49
 
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug
03-29 05:49
 
Disruption of a key ligand-H-bond network drives dissociative properties in vamorolone for Duchenne muscular dystrophy treatment
03-29 05:49
 
Vamorolone, a dissociative steroidal compound, reduces pro-inflammatory cytokine expression in glioma cells and increases activity and survival in a murine model of cortical tumor
03-29 05:49
 
The corticosteroid compounds prednisolone and vamorolone do not alter the nociception phenotype and exacerbate liver injury in sickle cell mice
03-29 05:49
 
Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes
03-29 05:49
 
Exposure-Response Analysis of Vamorolone (VBP15) in Boys With Duchenne Muscular Dystrophy
03-29 05:49
 
Vamorolone treatment improves skeletal muscle outcome in a critical illness myopathy rat model
03-29 05:49
 
Vamorolone, a dissociative steroidal compound, reduces collagen antibody-induced joint damage and inflammation when administered after disease onset
03-29 05:49
 
Population Pharmacokinetics of Vamorolone (VBP15) in Healthy Men and Boys With Duchenne Muscular Dystrophy
03-29 05:49
 
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy
03-29 05:49
 
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study
03-29 05:49
 
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function

Clinical Research News

今後の臨床試験

3
購読する